percent u.s. willing spend precious remaining days taking turn placebo randomized double blinded placebo controlled clinical trial way prove lithium actually slow als progression lithium not effect patients label opening effects missing opportunities try drugs work researchers faced enormous challenge incentive patients convinced lithium help enter trial placebo independently run lithium trials launched 2008 nontraditional designs hopes getting patients enroll allowed patients placebo group switch treatment group disease progressed historical control group allowed control group patients replace placebo lithium lower dosage patients dropped trials thought control group time patients 2.0 movement running trial introduced real time real world open nonblinded